Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Elisabet Berastegui

Elisabet Berastegui

Hospital Universitari Germans Trias i Pujol Spain

John M. Flack

John M. Flack

Southern Illinois University School of Medicine USA

Cristina Florescu

Cristina Florescu

Craiova University of Medicine and Pharmacy Romania

Mary Niu

Mary Niu

University of Oklahoma USA

Hamid Amer

Hamid Amer

King Abdulaziz Hospital – NGHA Saudi Arabia

Ashok Tahilyani

Ashok Tahilyani

Our Lady of Lourdes Hospital Ireland Ireland

Our Lady of Lourdes Hospital Ireland

Our Lady of Lourdes Hospital Ireland

Zulekha Hospitals UAE

M. Eileen Walsh

M. Eileen Walsh

College of Nursing at the University of Toledo USA

Recommended Global Cardiology Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

WORLD CARDIOLOGY 2024

About Conference

With the success of its previous series, Organizing Committee of medical specialty 2024 is glad to ask all the cardiologists, analysis students, students and alternative academicians to the future series 3rd International Conference on Cardiology with a Theme of Emerging Techniques and Advancements in Cardiology .The conference is meant with a subject of prediction and interference of cardiothearphy. This two-day event can cowl Keynote sessions of leading consultants, comprehensive talks and poster shows of researchers and alternative academicians, workshop sessions, exhibition and B2B conferences conducted by leading firms leaving a unforgettable expertise. medical specialty 2024 is one amongst the medical specialty conferences which is able to be visited by all the distinguished cardiologists, medical specialty educators, fiery inspectors, postgraduates, affiliations, business meanders below a solitary upside. This conference can give an in depth update on all clinical, surgical, and interventional, topics in medical specialty. consultants with national and international reputations in numerous fields can address the most recent tips, therapeutic approaches, recent trends, etc., in vessel medication. To boot, attendees can find out about recent trials being practiced that area unit possible to influence future practices.

Conference highlights include:

  • 100+ participants (Both Industry and academia)
  • 11+Keynote speakers
  • 30+ Plenary speakers
  • 10+ Exhibitors
  • Innovative educational sessions
  • B2B meetings
  • Hands-on Workshop

Why to attend?

Unlike all other conferences, Cardiology 2024 is meant to build a professional network among the people belonging to the same field. It also an excellent chance for the researchers to showcase their work and to gain support in moving further with their fascinating ideas by collaborating with the universities or leading companies. Medical graduates are offered an excellent opportunity to decide their future study interest by discussing with the professionals. The workshop sessions are meant to learn new treatment methods along with the knowledge of handling them in the future. The Delegates are benefited by being a part of all the conference sessions and to take part in the workshops, B2B meetings, and all other interactive sessions. Apart from the knowledge through talks, posters, and other sessions, the exhibitors provide you an additional experience by displaying their recent trends that keep you updated even with industrial advancements.

Target Audience:

 

  • Cardiologists
  • Scientists
  • Physicians/Consultants/ General Practitioners
  • Directors/Managers
  • Pathologists/ Nurses
  • Presidents & Vice Presidents/ Directors / Administrators
  • Business Entrepreneurs
  • Cardiology Associations/ Societies
  • Training Institutes
  • Young Researchers
  • Medical Students
  • Residents
  • Medical Devices Companies
  • Acadamic Scientists
  • Research Scholars
  • Business Delegates
  • Sonographers
  • Pharmacologists

Sessions & Tracks

Track 01: Cardiovascular Diseases

The term "cardiovascular disease" (CVD) is used to refer generally to conditions that affect the heart or blood vessels. Reduced blood flow to the body, brain, or heart can be brought on by: The accumulation of fatty deposits inside an artery that causes it to harden and narrow (thrombosis) and atherosclerosis. Cardiovascular diseases are specific forms of heart disease that affect kids and teenagers.  The autoimmune response is assumed to be the cause of rheumatic heart disorders, but the precise pathophysiology is yet unknown. When suffering from acute rheumatic fever, up to 39% of patients may experience varied degrees of pancarditis, which can lead to heart failure, pericarditis, and even death.

Acute coronary syndromes, congestive heart failure, inflammatory heart diseases, paediatric angina pectoris, ischemic heart diseases, rheumatic heart diseases, valvular heart diseases, peripheral artery diseases, pulmonary embolism, and vascular rings are more topics covered in this track. The main cause of death in the United States is cardiovascular disease. Understanding your heart is essential for preventing it. If you know what your sickness is and take care of yourself, you can live a healthier, more active life.

Track 02: Cardiac Stroke

Two of the leading causes of death in the US for both men and women are heart disease and stroke. The U.S. Centres for Disease Control and Prevention estimate that someone in the country dies of a heart attack every 90 seconds and a stroke every 4 minutes. Many of these deaths might be avoided with quick medical attention. Rapid action can also prevent the body from suffering lasting harm. The regular blood flow to the heart or brain, two vital organs, is disrupted, which leads to a heart attack or stroke. Heart or brain cells start to malfunction and die if they don't have access to oxygen-rich blood and nutrients. The body may experience a number of negative repercussions as a result of this cell loss. In the end, the modifications result in the well-known signs of a heart attack or a stroke.

A quick response from you, a friend, or a bystander at the first indication of any of these signs can make a significant difference. Every year, more Americans survive heart attacks and strokes because to research supported by the NIH. As long as medical assistance is received soon, modern medications, techniques, and gadgets can help limit heart and brain damage during an attack. 

 Track 03: Pediatric Cardiology

Paediatric cardiologists are experts in identifying and treating children's heart issues. Paediatric cardiologists and paediatric cardiac surgeons collaborate closely to choose the most effective therapies and strategies for children who could require heart surgery. Children may be impacted by a variety of heart diseases. Some structural variations are inherited. Some have to do with the electrical system that regulates pulse. Paediatric cardiologists have received specialised training to identify and treat these issues. Please explore whether a referral to a paediatric cardiologist is necessary with your child's paediatrician if you have concerns about your child's heart.

 

Children are not simply miniature adults. Children typically experience extremely different heart issues than do adults. For instance, children are more likely to be diagnosed with a cardiac condition than adults, although heart attacks in children are extremely uncommon. Cardiologists that specialise in treating children's hearts have received specialised training. Paediatricians who specialise in primary care work closely with paediatric cardiologists to deliver coordinated, all-inclusive care. Paediatric cardiologists frequently collaborate with other healthcare professionals since cardiac conditions in children can occasionally be complex and come with additional challenges. These professionals include neonatologists, cardiac paediatric intensivists, paediatric radiologists, paediatric heart surgeons, cardiac anesthesiologists, cardiac neonatologists, paediatric nurses, dietitians, and speech, occupational, and physical therapists.

Track 04: Interventional Cardiology

Catheters are used in interventional cardiology to detect and treat heart disease. Catheters are extremely tiny tubes that medical professionals insert into your blood arteries. They resemble IVs. This is the reason why a catheter-based operation doesn't require an incision. These types of cardiologists assist patients with vascular (blood vessel) and coronary (heart) ailments. Additionally, they support those with structural heart problems. These conditions include septal defects, which are irregularities in the walls dividing your heart chambers, and heart valve problems.

Some interventional cardiologists devote their entire professional lives to treating infants and children with congenital (present at birth) heart conditions. A minimally invasive operation on your heart or blood arteries is carried out by an interventional cardiologist using catheters. As a result, they won't need to do a sternotomy, a significant incision. They do not, however, do open heart surgery. The heart, lungs, and oesophagus are among the organs in your chest that a cardiothoracic surgeon can operate on. They perform these surgeries using open heart surgery as well as other techniques that need multiple small incisions rather than a single large one. The ideal treatment strategy for each patient is frequently determined by combining the two professions.

Track 05: Pediatric Heart Transplantation

Infant and kid heart transplantation is increasingly a common kind of treatment. Around 600–700 paediatric heart transplant surgeries are carried out year worldwide, accounting for roughly 12% of all heart transplants, according to the registry of the International Society for Heart and Lung Transplantation. 5307 paediatric heart transplants were carried out worldwide between 2010 and 2018. 488 of the 3817 heart transplants carried out in the United States in 2021 (or 13%) involved patients under the age of 17. Over the past ten years, the percentage of paediatric transplant patients by recipient age has remained largely steady. Congenital defects continue to be the most frequent reason for heart transplantation in neonates. One in 10,000 live babies experience congenital cardiomyopathy. Cardiomyopathy is the most frequent cause of heart transplantation in older kids. Growing numbers of kids get palliative surgery for congenital heart illness but later develop deteriorating cardiac function. The supposedly unsuccessful Fontan is a prime example. 10% of congenital heart disease cases are thought to be incurable. Hypoplastic left heart syndrome (HLHS), which affects roughly one in 6000 live births, is one of the most frequent causes of new born heart transplantation. Due to the shortage of cardiac donors and advancements in surgical palliation (i.e., the Norwood procedure, with or without the Sano modification), HLHS has become less of a justification for heart transplantation. See Paediatric Hypoplastic Left Heart Syndrome Surgical Treatment. Heart transplantation has changed over the past three decades from being primarily used to treat newborns with unrepaired HLHS to treating end-stage heart failure in adolescents and young people with palliated congenital heart disease.

Track 06: Fetal Cardiology

The foetus' circulatory system differs from that of a newborn baby because it does not use its own lungs until birth. Foetus refers to the developing child that is housed within the mother's uterus (the womb). The placenta, a unique organ, serves as the foetus' sole source of nutrition as it develops. The uterus is connected to one side of the placenta, while the liquid-filled sac that houses the foetus is connected to the other side. The placenta and the developing foetus are connected by a unique chord known as the umbilical cord. Through a thin layer of cells in the uterine wall, the mother's blood nourishes and oxygenates the foetus while also flushing out waste products like carbon dioxide. The circulatory and immune systems don't truly directly interact.

The circulatory system  of the foetus is distinct from that of a newborn baby because it does not use its own lungs until birth. The foetal heart does not need to pump blood to the lungs to take up oxygen before birth. In other words, the pulmonary artery and aorta do not need to be separate for the foetal heart. These two blood veins are linked in the foetal heart by a blood channel known as the ductus arteriosus. The ductus shuts after birth, and a distinct left pulmonary artery and aorta develop.

Track 07: Nuclear Cardiology

Noninvasive methods are used in nuclear cardiology studies to measure myocardial blood flow, assess the heart's ability to pump blood, and identify the magnitude and location of a heart attack. Myocardial perfusion imaging is the method of nuclear cardiology that is most frequently employed.  Exercise is used in conjunction with myocardial perfusion pictures to measure blood flow to the heart muscle. Walking on a treadmill or riding a stationary bike are two ways to get exercise. Patients who are unable to exercise to their fullest capacity can undergo a "chemical" stress test utilising the drugs dipyridamole, adenosine, regadenoson, or dobutamine, which provides comparable data on the heart's blood flow.

Radionuclide ventriculography is a noninvasive procedure that sheds light on the heart's pumping mechanism. Evaluation of the heart's ability to pump blood (also known as the ejection fraction) is crucial in predicting both long-term and short-term survival in patients with coronary artery disease and those who have experienced a heart attack. The four chambers of the heart are photographed using a specialised camera called a gamma camera after a little amount of an imaging agent is introduced into the bloodstream. Additionally, these methods can be used to monitor the impact of various medications on the heart muscle and offer data on the health of all cardiac chambers, valve function, and valve integrity.

Track 08: Cardiology and Covid 19

Acute respiratory distress syndrome, cardiogenic shock, thromboembolic events, and death were among the serious complications that the early reports on the epidemiology of coronavirus disease 2019 (COVID-19) from Wuhan, China, warned would likely occur in elderly patients and those who already had cardiovascular disease. Subsequently, these findings have been supported by a wide range of reports from around the world, including US and European investigations. There are various possibilities, however the mechanisms causing this vulnerability have not yet been fully understood. Some of these unfavourable effects might be a reflection of the inherent fragility of older people with chronic illnesses who are stressed by severe pneumonia infections that are similar to influenza infections.

Furthermore, among patients with chronic coronary artery disease, an episode of acute systemic inflammation might also contribute to plaque instability, thus precipitating acute coronary syndromes, as has also been reported during influenza outbreaks. Development of type 2 myocardial infarction related to increased myocardial oxygen demand in the setting of hypoxia may also be a primary concern. Severe COVID-19 infections are characterised by arterial or venous thrombosis, which is linked to vascular damage and the prothrombotic cytokines generated during the protracted systemic inflammatory and immunological responses.3 As a result, there is a higher risk of developing severe thrombotic consequences, such as acute coronary syndrome, ischemic stroke, pulmonary embolism, and ischemia damage to numerous other organ systems. Such occurrences can alter the course of any COVID-19 patient, but they would be more devastating to those who already have cardiovascular disease.

Track 09: Cardiac Pharmacology

The field of cardiovascular pharmacology includes the classes of medications used to treat and manage cardiovascular diseases include hypertension, heart failure, angina, and arrhythmias. One of the most significant public health issues and a significant financial burden on Western healthcare systems is cardiovascular disease. The functionality and quality of life of those who are impacted by them might be seriously compromised by their associated morbidity. The majority of cardiovascular emergencies are managed with the use of pharmaceutical therapy. The medication used to treat acute coronary syndromes, acute heart failure, and different arrhythmias is reviewed in this article. The emphasis will be on giving useful advice that may be used at the bedside in the emergency room.

Cardiovascular pharmacology is concerned with how medications affect the heart and vascular system as well as the basic workings of cardiovascular cells. Researchers in the department use cutting-edge technology to study the causes of sudden cardiac death, congenital arrhythmias, and the cardiac toxicity of chemotherapy medications. These include induced pluripotent stem cells, automated electrophysiology, and genomics.

Track 10: Hypertension

The arteries in the body are impacted by the prevalent condition of high blood pressure. Additionally known as hypertension. The blood's constant pressure against the artery walls is too high if you have high blood pressure. To pump blood, the heart has to work harder. Millimetres of mercury, or mm Hg, are used to measure blood pressure. A blood pressure reading of 130/80 mm Hg or greater is generally regarded as hypertension.

The American Heart Association and the American College of Cardiology classify blood pressure into four broad categories. Normal blood pressure is considered to be ideal.)

  • Healthy blood pressure. At least 120/80 mm Hg for blood pressure.
  • High blood pressure. The bottom number is below, not over, 80 mm Hg, and the top number falls between 120 and 129 mm Hg.
  • First-stage hypertension. The top number is in the 130–139 mm Hg range, and the bottom number is in the 80–89 mm Hg range.
  • Second-stage hypertension. The top number is at least 140 millimetres of mercury, or the bottom number is at least 90.

A hypertensive emergency or crisis is defined to have a blood pressure reading of greater than 180/120 mm Hg. If you or someone you know has these blood pressure readings, get emergency medical treatment. High blood pressure raises the risk of heart attack, stroke, and other major health issues if left untreated. Starting at age 18, it's critical to have your blood pressure monitored at least every two years. Some people require more frequent examinations. High blood pressure can be prevented and treated with healthy lifestyle choices like quitting smoking, exercising, and eating well. Some individuals require medication to lower their blood pressure.

Track 11:  Women’s Cardiology

A healthy heart appears almost the same inside our bodies. Your heart health is special for women because of this. The tiny physical variations in women's hearts make them more susceptible to a variety of heart-related problems. The leading cause of death for women in the US is heart disease. It's critical to understand your risk factors and to consult a doctor if you have any worries. We're here to support you in leading the heart-healthiest life possible thanks to our female-focused cardiologists.

With the widely held belief that it is impossible to combine training and the responsibilities of the work with raising a family, women have far too frequently been deliberately discouraged from pursuing a career in cardiology. The mix of cardiology and care responsibilities is undoubtedly difficult, but this out-of-date belief is simply wrong. Numerous cardiologists in the UK many of them women prove daily that it's possible to strike a balance between work and life and succeed in both environments. Despite this, female medical students and trainees continue to report active dissuasion from a future in cardiology by physicians, both those practising cardiology and those in other specialties, who appear to have the best intentions.

  • Etiology, Epidemiology
  • Pathophysiology
  • History and Physical Evaluation
  • Treatment / Management
  •  Differential Diagnosis
  • Pertinent Studies and Ongoing Trials
  • Deterrence and Patient Education
  • Enhancing Healthcare Team Outcomes

Track 12: Cardiomyopathy and Stroke

Patients with ischemic stroke (IS), mortality, cardiovascular death, all strokes, and significant cardiovascular events, such as rehospitalisation for heart failure and ventricular arrhythmias resulting in cardiac arrest, are at a high risk of developing hypertrophic cardiomyopathy (HCM).

  •  Particularly if atrial fibrillation (AF) is also present, these risks are amplified.
  •  To help identify those HCM at higher risk of IS, risk stratification needs to be improved, especially using easy-to-use methods.
  • The HCM Risk-CVA (cerebrovascular accident) score can be used to predict IS using a sophisticated weighted score that takes into account factors such age, the existence of AF, the age at which AF first appeared, prior thromboembolism, New York Heart Association class, left atrial size, mean wall thickness, and vascular disease.
  • According to data from the Korean nationwide cohort, individuals with AF and HCM who did not have any nongender CHA2DS2-VASc stroke risk factors had an IS/systemic embolism rate of 4.02 per 100 person-years, which was almost as high as the rate for patients with AF without HCM who had a CHA2DS2-VASc score of 3 (4.07 per 100 person-years).
  • Similar to earlier studies using the CHA2DS2-VASc score in the non-HCM population, the CHA2DS2-VASc score demonstrated a modest predictive value for IS (c-index 0.65).

Track 13: Cardiovascular Imaging and Image Analysis

Cardiovascular imaging is a diagnostic radiography that uses medical images to identify heart abnormalities and diagnose cardiovascular disorders. It is used to identify a variety of illnesses, including:

  • Cardiovascular disease.
  • Valve issues or heart failure.
  • An attack of the heart's damage.
  • Inherited cardiac conditions
  • Pericarditis
  • Heart tumours.

Image analysis involves breaking down an image into its basic elements and removing any relevant information. Finding shapes, eliminating noise, counting objects, spotting edges, and generating statistics for texture analysis or image quality are just a few of the activities involved in image analysis. Here are some techniques for image processing:

  • Image processing in analogue
  • Digitization of images

Track 14: Heart Transplantation

A failing heart is replaced with a healthier donor heart during a heart transplant procedure. People who need a heart transplant are typically those whose conditions haven't improved enough with medication or other procedures. Even though a heart transplant is a big procedure, your chances of survival are strong with the right aftercare.

When other methods of treating cardiac issues have failed and heart failure has resulted, heart transplants are done. Adults may get heart failure due to:

  • Heart muscle deterioration (cardiomyopathy)
  • Cardiovascular disease
  • Heart valve dysfunction
  • A birth abnormality of the heart (congenital heart defect)
  • Ventricular arrhythmias that are dangerously recurrent and are not under control with conventional therapies a previous heart transplant failed

Among multiorgan transplants are:

  • Kidney and heart transplant. Some patients with both kidney and heart failure may be candidates for this surgery.
  • Liver and heart transplant. For those with specific liver and cardiovascular issues, this treatment might be an option.
  • Lung and heart transplant. Rarely, if a heart transplant or lung transplant alone cannot cure a patient's severe lung and heart issues, a specialist may recommend this operation.

Track 15 : Cardiovascular diseases during pregnancy

Obstacles specific to cardiovascular disease during pregnancy can arise. Along with other pregnancy-related changes, increased blood volume and heart rate can place additional stress on the heart, complicating pre-existing diseases and introducing new cardiovascular problems. As part of the Cardiovascular illness and Pregnancy Programme at Brigham and Women's Hospital (BWH), we offer highly specialised care for women with cardiovascular illness before, during, and after pregnancy. Our interdisciplinary team of professionals, which consists of cardiologists, interventional cardiologists, cardiac surgeons, maternal-fetal medicine (high-risk pregnancy) specialists, and specialised nurses, is committed to providing the woman and her unborn child with the best possible care.

Heart disease that was present before may include:

  • Defects and congenital heart disease
  • Arrhythmias, or abnormal heart rhythms
  • Hypertension, or high blood pressure
  • Heart structural disease
  • Cardiovascular disease
  • Vascular illness

Track 16:  Cardiac Electrophysiology

A sequence of tests that look at the electrical activity of the heart is known as an electrophysiology (EP) investigation, sometimes known as an invasive cardiac electrophysiology study. The electrical activity of the heart generates signals (or impulses) that regulate the frequency of heartbeats. Cardiologists may draw a very precise map of how these signals flow between each heartbeat during an EP investigation.

A medical professional can see in great detail how electrical signals go through the heart thanks to an EP research. An EP study may be suggested by your doctor if:

  • You have an arrhythmia, or irregular heartbeat. Your doctor may advise an EP study if you have been diagnosed with supraventricular tachycardia (SVT) or another type of tachycardia in order to establish the best course of treatment.
  • You fell down. An ECG can help identify the reason of a sudden loss of consciousness (fainting or syncope).
  • You are susceptible to abrupt cardiac death. An EP study can assist estimate your risk of sudden cardiac death if you have specific heart issues.
  • Cardiac ablation is required. Cardiac ablation corrects issues with cardiac rhythm by applying heat or cold energy. Prior to cardiac ablation, an EP study is always performed to identify the source of the abnormal heart rhythm. An EP exam and cardiac ablation may be performed on the same day as heart surgery.

Benefits of Participation

  • The advantages of the speaker and abstract pages are created in Google on your profile under your name would get worldwide visibility.
  • Our comprehensive online advertising attracts 30000+ users and 50000+ views to our Library of Abstracts, which takes researchers and speakers to our conference.
  • Meet with hundreds of like-minded experts who are pioneers in COPD 2023 and share ideas.
  • All participants in the conference would have a different reason to participate with eminent speakers and renowned keynote speakers in one-to-one meetings.
  • A rare opportunity to listen what the world's experts are learning about from the world's most influential researchers in the area of cardiology at our Keynote sessions.
  • COPD 2023 intensive Conference schedule, you will acquire experience and expertise in strategic gift preparation that is worth its weight golf, forming an impressive array of recognized professionals.
  • Best Poster Award nominations.
  • Award for Outstanding young researcher
  • Group Registration Advantages.

Benefits of Participation for Speaker

  • Access to all Sessions (Keynote, Plenary, Poster, E-Poster)
  • Certificate Accreditation from the Organizing Committee
  • Abstracts will be published in the conference souvenir and respective international journal
  • Each registrant will get 50% abatement on manuscript publication fees
  • Access to the attendees email list (post conference)
  • Worldwide appreciation of the profile of research
  • Obtain credits for professional growth.
  • Explore the latest of cutting edge analysis.
  • Make long-term bonds at social and networking activities.
  • An ability to advertise one page in the distribution of abstract books and flyers that ultimately gets 1 million views and adds great value to your research profile.
  • Learn a transition beyond your area of interest to learn more about new subjects and studies away from your core subject of cardiology
  • We have distinctive networking, learning and enjoyable integration into a single package.

Benefits of Participation for Delegate

  • Professional Development-Improve understanding and knowledge
  • Attendance at conferences supports rejuvenates and energizes delegates.
  • Your involvement in our conference will help with a new methodology and ideology that can be used to broaden the outcomes of business or industries.
  • Opportunities for World Cardiology 2024 researchers and experts in the same field to meet and exchange new ideas through a Cardiology Conference.  

Benefits of Participation for Sponsor

  • Exposure to the international environment would increase the possibility of new companies
  • Opportunity to demonstrate your company's latest technologies, new products, or service your business to a wide range of international participants.
  • Increase business by our conference participants through lead generation.
  • It takes a lot of time, effort and drive to create a successful company, so it's always nice to have a network of colleagues and associates to draw energy from individuals who share a common drive and objective.
  • Conferences in cardiology provide opportunities for more attention and contemplation that could help you move your company to the next stage.
  • Benchmarking main organisation  plans

 

To Collaborate Scientific Professionals around the World

Conference Date February 08-09, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Experimental cardiology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by